Formulation development and evaluation of Orally Disintegrating Tablets Rizatriptan Benzoate

Saibabu Ch; Triveni P

doi:10.46796/ijpc.v2i4.246

Ch,Saibabu Head , Department of Pharmaceutics, M.L. College of Pharmacy, S. Konda-523101
P.Triveni Department of Pharmaceutics, M.L. College of Pharmacy, S. Konda-523101

DOI https://doi.org/10.46796/ijpc.v2i4.246

Abstract

Formulation research is oriented towards safety, efficacy and quick onset of action of existing drug molecule through novel concepts of drug delivery. Orally disintegrating tablets of Rizatriptan benzoate were prepared by direct compression method to provide faster relief from pain to migraine sufferers. About eleven formulations for the present study were carried out. Croscarmellose sodium, Crospovidone and Sodium starch glycolate (SSG) were used as superdisintegrants, while microcrystalline cellulose was used as diluent. The prepared batches of tablets were evaluated for weight variation, hardness, friability, wetting time, invitro dispersion time, drug content and invitro dissolution studies. The formulation containing combination of Croscarmellose sodium and Sodium starch glycolate showed rapid invitro dispersion time as compared to other formulations. The optimized formulation dispersed in 8 seconds. It also showed a higher water absorption ratio and 99.58% of drug is released within 2 minutes.

Keywords: Orally disintegrating tablets, Superdisintegrants, Rizatriptan benzoate, Direct compression

Downloads

Download data is not yet available.

References

1. Rangasamy Manivannan. Oral disintegrating tablets: A future Compaction Publication. International Journal of Pharmaceutical Research and Development 2009; 1: 1-10.
2. Mishra DN, Bindal M, Singh SK. Rapidly disintegrating oral tablet of valdecoxib. Indian drug. 2004; 41: 554.
3. Kaushik D, Dureja H, Saini TR. Mouth dissolving tablets: A review. Indian Drugs. 2004; 41: 503-508.
4. Ansel HC, Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery system. B.I. Waverly Pvt. Ltd, New Delhi. 1995; 6:99-154.
5. Goodman, Gilman's. The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill, 2006, pp 305-9.
6. Sanford B, Eds in pharmaceutical statistics, Practical and clinical applications, 2nd Edn, Marcel Dekker. NY, 1990, pp 303-337.
7. Wade A, and waul , P.J, Eds, in hand book of pharmaceutical excipients, ed 2, American pharmaceutical association, Washington, pharmaceutical press, London, 1994.
8. Banker G.S, Anderson N. R. In: Lachman L, Lieberman H.A. and Kanig J.L. The Theory and Practice of Industrial Pharmacy. 3rd ed, Mumbai, Varghese Publishing House, 1987, pp 293-399.
9. Sreenivas S.A, Gadad A.P, Patil M.B. Formulation and evaluation of ondasetron hydrochloride directly compressed mouth disintegrating tablets. Indian Drugs, 2006: 43: 35-37.
10. Kundu S, Sahoo P.K. Recent trends in the developments of orally disintegrating technology. Pharma Times, 2008; 40: 11-15.
11. Gohel MC, Bansal G, Bhatt N. Formulation and evaluation of orodispersible taste masked tablets of famotidine. Pharma Biol World 2005; 3: 75-80.
12. United State Phamacopoeia . Convention. NF Asian edition, 2004, pp 74-75.
13. Marabathuni VJ, Dinesh P, Ravikumar R, Yamini P, Kiran PS, Hussain SP, Rao CM. Chitosan based sustained release mucoadhesive buccal patches containing amlodipine besylate (AMB). Asian J Res Pharm Sci. 2017 Jun 28;7:97-104.
14. Marabathuni VJ, Bhavani M, Lavanya M, Padmaja K, Madhavi N, Babu P, Rao CM. Formulation and evaluation of mouth dissolving Tablets of carbamazepine. Asian Journal of Pharmacy and Technology. 2017;7(3):137-43.